Australia's most trusted
source of pharma news
Wednesday, 10 December 2025
Posted 9 December 2025 AM
Arrotex has launched the first generic version of a GSK prescription medicine to treat a common ailment.
GSK's Avamys, a once-daily intranasal corticosteroid, is used for the treatment of seasonal allergic rhinitis and perennial allergic rhinitis in people aged two years and older. A spray with 120 doses sells for around $48 in chemists.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.